Digital Health, Drug Development and Strategy

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health. Learn more at koneksahealth.com.

Life Science

Life Science Drug Development BioTech Leadership

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Digital Health Global

JANUARY 4, 2024

Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Chief Medical Officer, Koneksa. Chief Scientific Officer, Koneksa.

Digital Health

Digital Health Health Technology Drug Development healthcare technology

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

APRIL 25, 2024

This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By

Health Data

Health Data BioTech Drug Development healthcare technology

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care.

Pharmaceuticals

Pharmaceuticals Drug Development Digital Health

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development

Drug Development Digital Health

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health

Digital Health Drug Development Telemedicine Telehealth

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development

Drug Development eMed BioTech Digital Health

Vital Lines September 2023

Redox

SEPTEMBER 26, 2023

Top stories CMS creates all-payer model for states CMS is offering an all-payer funding opportunity of up to $12M for eight states to improve population health. Don’t get so immersed in system processing that you overlook data quality and accessibility, says Deloitte’s Cloud Strategy Officer.

FHIR

FHIR Drug Development Telehealth Digital Health

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa.

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.

healthcare technology

healthcare technology Drug Development Leadership Digital Health

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science

Life Science Drug Development BioTech Pharmaceuticals

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

Drug Development

Drug Development Health science healthcare technology Leadership

What can Healthcare AI learn from Weather AI?

Lloyd Price

MAY 6, 2024

Healthcare AI can adopt similar strategies to integrate and analyse diverse patient data, including medical records, environmental factors, genetic data, and sensor data from wearables. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

APRIL 22, 2024

Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Pharmaceuticals

Pharmaceuticals healthcare technology Digital Health Remote care

Health Consumers Are Now Amazon-Primed for Healthcare – HealthConsuming Explains, Part 2

Health Populi

APRIL 29, 2019

consumer has raised peoples’ expectations of what health care services could be: personalized, customized, anticipatory, immediate or on-schedule, and convenient – where we live, work, play, pray, learn and even drive.” The company has been multi-tasking a broad range of tactics throughout the health care ecosystem.

HIPAA

HIPAA Drug Development Digital Health Mental health

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science

Life Science Drug Development Digital Health Health IT

Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” Find out more: www.sanofiventures.com.

Life Science

Life Science BioTech Drug Development Digital Health

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Pharmaceuticals

Pharmaceuticals healthcare technology Leadership Drug Development

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals

Pharmaceuticals Digital Health Drug Development Life Science

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

FEBRUARY 22, 2024

Technological advancements: New technologies offer more personalised, data-driven, and effective pain management strategies. Tech-driven Solutions: Digital Therapeutics (DTx): App-based solutions offering personalized pain management programs, education, and support. The global pain management market is expected to reach $3.3

Pain management

Pain management Mental health Telehealth healthcare technology

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

FEBRUARY 2, 2024

Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data

Health Data Interoperability healthcare technology Leadership

Digital Health Technologies in Clinical Trials

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.

Health Technology

Health Technology Digital Health Life Science BioTech

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

MARCH 16, 2023

About Wellington Partners Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totaling more than €1.2 Forbion manages well over EUR 2.3

Life Science

Life Science Pharmaceuticals BioTech Drug Development

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

Xealth

JUNE 27, 2023

David Slifka, Vice President, Commercial Enablement The digital health ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digital health ecosystem.

Digital Health

Digital Health Drug Development Pharmaceuticals EHR

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients.

Life Science

Life Science Digital Health Drug Development Patient Experience

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Lloyd Price

APRIL 29, 2024

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

Health Data

Health Data healthcare technology Digital Health Leadership

Digital Therapeutics: the keys to succeed!

Digital Health Today

AUGUST 7, 2019

DTx could be used in phase II of clinical trials for monitoring patients, helping reduce costs of drug development and speeding up that phase. Talk to them early on to create a pathway for the next 2-6-10 years, with different possible strategies. Digital Health Today would not be possible without our valuable partners.

Pharmaceuticals

Pharmaceuticals Digital Health Drug Development Primary Care

The outlook for healthcare in 2022

Waracle

JANUARY 5, 2022

Since their first compound DSP-1181, which was designed to help with OCD treatment, went into clinical trials, they have developed multiple other compounds using AI. In fact, Exscientia stands by the claim that all drugs in the future will be made using AI. . The post The outlook for healthcare in 2022 appeared first on Waracle.

Patient Experience

Patient Experience Drug Development Digital Health Remote care

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech

BioTech Drug Development Life Science Pharmaceuticals

Connected Health Pulse

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Trending Sources

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

The next revolution in the pharmaceutical industry: the transformative potential of AI

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Vital Lines September 2023

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

What can Healthcare AI learn from Weather AI?

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Where are HealthTech's soft landing M&A deals in today's market?

Health Consumers Are Now Amazon-Primed for Healthcare – HealthConsuming Explains, Part 2

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Self-sovereign identity (SSI) - the future of Health Data?

Digital Health Technologies in Clinical Trials

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Digital Therapeutics: the keys to succeed!

The outlook for healthcare in 2022

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Stay Connected